Advanced search×

Glaucoma medication during pregnancy and nursing.

Bull Soc Belge Ophtalmol (2010) PMID 20480749

Risks that glaucoma medications pose to the fetus and neonate must be balanced against the risk of vision loss in the mother. There is no high level evidence for harmful effects on the fetus and neonate of medications used to treat glaucoma. All topical and systemic glaucoma medication should be avoided during the first trimester of pregnancy. Systemic carbonic anhydrase inhibitors, topical prostaglandin analogues and antimetabolites during surgery should be avoided absolutely. Some topical medications are deemed compatible with lactation by the American Academy of Pediatrics, however, caution should still be practiced.

Version: za2963e q8za7 q8zb5 q8zcf q8zde q8zeb q8zf1 q8zgd

Similar articles you may find interesting…

  1. Epoxides as stable detoxification products of some tricyclic drugs.

    Boll Chim Farm 114(8):421-3 (1975) PMID 1182060

  2. Human pharmacokinetics and tolerability of L-697,639, a non-nucleoside HIV-1 reverse transcriptase inhibitor.

    Int J Clin Pharmacol Res 14(2):45-50 (1994) PMID 7530697

    L-697,639, a potent and selective non-nucleoside inhibitor of HIV-1 reverse transcriptase and HIV-1 replication in vitro, was administered to healthy male volunteers to investigate the pharmacokinetics and tolerability of single and multiple oral doses. Single doses ranging from 25 to 500 mg, and mu...
  3. betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932.

    Mol Cell Biol 23(1):402-13 (2003) PMID 12482991 PMCID 140687

    NF-kappaB1 p105 functions both as a precursor of NF-kappaB1 p50 and as a cytoplasmic inhibitor of NF-kappaB. Following the stimulation of cells with tumor necrosis factor alpha (TNF-alpha), the IkappaB kinase (IKK) complex rapidly phosphorylates NF-kappaB1 p105 on serine 927 in the PEST region. This...